Akso Health Group Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 24, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	1,294	1,953	651	507	8	39
Market Cap Growth	86.98%	199.95%	28.41%	6147.27%	-78.99%	34.82%
Enterprise Value	1,296	1,953	475.08	422	0.31	20.22
Last Close Price	1.51	2.28	1.18	1.16	0.36	1.69
Forward PE	-	-	5.08	5.08	5.08	5.08
PEG Ratio	-	-	0.51	0.51	0.51	0.51
PS Ratio	93.52	-	-	-	0.62	6.44
PB Ratio	7.15	10.80	3.27	3.67	0.93	3.15
P/TBV Ratio	6.03	9.11	1.87	0.40	2.79	8.20
P/FCF Ratio	-	-	636.74	375.30	-	-
P/OCF Ratio	-	-	553.19	375.30	-	-
EV/Sales Ratio	93.68	-	-	-	0.02	3.37
EV/FCF Ratio	-	-	464.53	312.31	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0	0	0
Debt / FCF Ratio	-	-	0.08	-	-	-
Net Debt / Equity Ratio	0.00	0.00	-0.88	-0.62	-0.91	-1.50
Net Debt / EBITDA Ratio	-0.01	-0.01	1.07	9.86	0.56	5.65
Net Debt / FCF Ratio	0.00	-0.02	-172.24	-63.03	2.44	2.14
Asset Turnover	-	0	0	0	0.32	0.13
Inventory Turnover	69.17	70.92	78.96	2.44	2.51	1.38
Quick Ratio	0.17	0.17	13.69	23.70	1.48	0.76
Current Ratio	21.77	21.77	14.20	39.52	1.76	1.24
Return on Equity (ROE)	-10.34%	-9.85%	-80.26%	-12.38%	-123.87%	-27.75%
Return on Assets (ROA)	-9.87%	-9.25%	-75.91%	-10.66%	-34.31%	-7.06%
Return on Invested Capital (ROIC)	-10.33%	-18.33%	-355.39%	-31.98%	-	-111.23%
Return on Capital Employed (ROCE)	-11.44%	-10.84%	-97.95%	-11.73%	-135.07%	-22.06%
FCF Yield	-	-	0.16%	0.27%	-	-
Buyback Yield / Dilution	-204.20%	-153.50%	-504.37%	31.23%	-15.07%	-22.06%
Total Shareholder Return	-204.20%	-153.50%	-504.37%	31.23%	-15.07%	-22.06%

SEC Filings: 10-K · 10-Q